2Bone RC,Balk RA,Cerra FB,et al.The ACCP/SCCM consensus conference committee.Definitions for sepsis and organ failure and guidelines for the use ofinnovative therapies in sepsis[J].Chest,1992,101(5):1656.
3Mulder J, Tan H, Bellomo R, et at. Platelet loss across the hemofilter during continuous hemofiltration [ J ]. Int J Artif Organs, 2003, 10(26) :906-912.
4Boldt J, Menges T, Wollbruck M, et al. Platelet function in critically ill patients[J]. Chest, 1994,106:899-903.
5Maria RH, Ana MG, Aleix C, et al. Biocompatibility of cellulosic and synthetic membranes assessed by leukocyte activation [J]. Am J Nephrol, 2004,24:235-24.
6Docoi D, Turcl F, DelVecchio C, et al. Hemodialysis-associated platelet loss:study of the relative contribution of dialyzer membrane composition and geometry [ J] . Int J Artif Organs, 1984,7 : 337- 340.
7CHAING DT, ANOZIE A, FLEMING W R, et al. Comparative study on acute pancreatitis management[J]. ANZ J Surg,2004,74 (4) :218-221.
8KINGSNORTH A. Role of cytokines and their inhibitors in acute pancreatitis[J]. Gut, 1997,40 (1) : 1-4.
9SCHETZ M R C. Classical and alternative indication for continuous renal replacement therapy[J]. Kindey Int,1998, 53 (66): 129-132.
10BONE R C, BALK R A, CERRA F B, et al. The ACCP/SCCM consensus conference committee. Definitions for sepsis and organ failure and guidelines for the use ofinnovative therapies in sepsis [J]. Chest,1992,101(5):1656-1662.
10Hirota M, Takada T, Kitamura N, et al. Fundamen- tal and intensive care of acute pancreatitis[J]. J Hepa- tobiliary Pancreat Sci, 2010,17 (1) : 45-52.
